Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 256940203 approvals1 trials

Keeps Biopharma Inc.

Official website

Founded in 2000 and listed on KOSDAQ in 2017, Keeps Biopharma transitioned from OLED equipment to pharmaceuticals through its 2025 merger with Korea Global Pharm.

Price

Change

Market cap

Products & technology

  • Globdexy Tab. (dexibuprofen)Anti-inflammatory analgesic
  • Globsta Tab. (atorvastatin calcium hydrate)Lipid-lowering agent
  • OraloidOral delivery platform for peptide therapeutics (insulin, GLP-1, PTH)

Regulatory approvals

data.go.kr

203 Korean MFDS drug approvals · 1999–2026

  • MFDS drugRovaampin Tab. 5/5mg2026-04-03
    Drug · Prescription · Approval202600950
  • MFDS drugRovaampin Tab. 10/5mg2026-03-30
    Drug · Prescription · Approval202600884
  • MFDS drugRovaampin Tab. 20/5mg2026-03-30
    Drug · Prescription · Approval202600885
  • MFDS drugNAD Tab.2026-01-19
    Drug · OTC · Notification202600160
  • MFDS drugMyborn Tab.2025-03-18
    Drug · OTC · Notification202500613
  • MFDS drugVentiMeganice Tab.2025-02-03
    Drug · OTC · Notification202500212
  • MFDS drugGlogingko Tab. 240mg (Ginkgo Leaf Dried Extract)2024-10-14
    Drug · OTC · Notification202402424
  • MFDS drugGloCaID Tab.2024-07-29
    Drug · OTC · Notification202401821
  • MFDS drugRomantin Tab. 20mg2024-07-11
    Drug · Prescription · Approval202401709
  • MFDS drugGlositaformin Tab. 50/1000mg2023-03-13
    Drug · Prescription · Approval202300845
  • MFDS drugGlositaformin Tab. 50/850mg2023-03-13
    Drug · Prescription · Approval202300846
  • MFDS drugGlositaformin Tab. 50/500mg2023-03-13
    Drug · Prescription · Approval202300847
Show 68 more
  • MFDS drugGlositaformin SR Tab. 50/500mg2023-02-17
    Drug · Prescription · Approval202300606
  • MFDS drugGlositaformin SR Tab. 50/1000mg2023-02-17
    Drug · Prescription · Approval202300607
  • MFDS drugGlositaformin SR Tab. 100/1000mg2023-02-17
    Drug · Prescription · Approval202300608
  • MFDS drugAdikarb Tab. 30/2.5mg2023-01-06
    Drug · Prescription · Approval202300083
  • MFDS drugAdikarb Tab. 60/5mg2023-01-06
    Drug · Prescription · Approval202300093
  • MFDS drugAdikarb Tab. 60/2.5mg2023-01-06
    Drug · Prescription · Approval202300118
  • MFDS drugGlofen Inj.2022-06-07
    Drug · Prescription · Notification202202367
  • MFDS drugRMS Arginin Solution2022-05-30
    Drug · OTC · Notification202202287
  • MFDS drugDobes Tab. 500mg2022-01-10
    Drug · Prescription · Approval202200188
  • MFDS drugGlositagle Tab. 25mg(Sitagliptin hydrochloride monohydrate)2021-03-31
    Drug · Prescription · Approval202102830
  • MFDS drugGlositagle Tab. 50mg( Sitagliptin hydrochloride monohydrate)2021-03-31
    Drug · Prescription · Approval202102831
  • MFDS drugGlositagle Tab. 100mg(Sitagliptin hydrochloride monohydrate)2021-03-31
    Drug · Prescription · Approval202102832
  • MFDS drugEMpa Tab. 10mg2021-03-05
    Drug · Prescription · Approval202102097
  • MFDS drugEMpa Tab. 25mg2021-03-04
    Drug · Prescription · Approval202102033
  • MFDS drugEMpa Tab. 10mgRevoked2021-03-04
    Drug · Prescription · Approval202102034
  • MFDS drugGlozet Tab. 10/10mg2021-02-18
    Drug · Prescription · Approval202101421
  • MFDS drugGlozet Tab. 10/20mg2021-02-18
    Drug · Prescription · Approval202101422
  • MFDS drugPret Eye Drops2021-01-14
    Drug · Prescription · Notification202100394
  • MFDS drugLevohi Eye Drops 1.5%2021-01-04
    Drug · Prescription · Approval202100015
  • MFDS drugDapa Tab. 10mg(Dapagliflozin)Revoked2020-12-15
    Drug · Prescription · Approval202008794
  • MFDS drugGlotica Tab. 90mg(Ticagrelor)Revoked2020-11-11
    Drug · Prescription · Approval202007772
  • MFDS drugGlotica Tab. 60mg(Ticagrelor)Revoked2020-10-16
    Drug · Prescription · Approval202007097
  • MFDS drugTapadine Eye Drops 0.2%(single use)2020-10-08
    Drug · Prescription · Approval202006848
  • MFDS drugS-Vil Ibu Soft Cap. 200mg2020-06-29
    Drug · OTC · Notification202004710
  • MFDS drugGlarmac Tab.Revoked2020-05-29
    Drug · Prescription · Approval202004101
  • MFDS drugGlomega Soft Cap.2020-05-29
    Drug · Prescription · Approval202004108
  • MFDS drugUmero Tab. 20/20mg2020-05-28
    Drug · Prescription · Approval202003953
  • MFDS drugUmero Tab. 20/10mg2020-05-28
    Drug · Prescription · Approval202003954
  • MFDS drugUmero Tab. 20/5mg2020-05-28
    Drug · Prescription · Approval202003955
  • MFDS drugTamlos SR cap. 0.4mg2020-04-22
    Drug · Prescription · Approval202002881
  • MFDS drugBrolase Enteric Coated Tab.2020-04-10
    Drug · OTC · Notification202002542
  • MFDS drugGlophylline Cap.Revoked2020-04-02
    Drug · Prescription · Approval202002297
  • MFDS drugAllertin Tab. 10mgRevoked2020-03-25
    Drug · Prescription · Approval202002070
  • MFDS drugAllertin Tab. 20mgRevoked2020-03-25
    Drug · Prescription · Approval202002071
  • MFDS drugGlatidine Tab.Revoked2020-03-20
    Drug · Prescription · Approval202002003
  • MFDS drugDobes Tab.2020-03-18
    Drug · Prescription · Approval202001903
  • MFDS drugPgalin Cap. 75mg2020-02-21
    Drug · Prescription · Approval202001235
  • MFDS drugPgalin Cap. 150mg2020-02-21
    Drug · Prescription · Approval202001236
  • MFDS drugKoetin SR Cap.2020-02-20
    Drug · Prescription · Approval202001223
  • MFDS drugCoxgrin Cap. 100mg2020-01-10
    Drug · Prescription · Approval202000176
  • MFDS drugGloerisone SR Tab.2019-12-24
    Drug · Prescription · Approval201908623
  • MFDS drugDuo Bactam Tab. 500mg2019-11-13
    Drug · Prescription · Approval201907911
  • MFDS drugRasamin Tab. 0.5mg2019-10-30
    Drug · Prescription · Approval201907568
  • MFDS drugRasamin Tab.2019-10-30
    Drug · Prescription · Approval201907569
  • MFDS drugGloTelmitan Tab. 80mg(Telmisartan)Revoked2019-09-10
    Drug · Prescription · Approval201906392
  • MFDS drugGloTelmitan Tab. 40mgRevoked2019-08-21
    Drug · Prescription · Approval201905912
  • MFDS drugNUADIN TAB2019-05-31
    Drug · Prescription · Approval201903636
  • MFDS drugCiloretal SR Cap. 100mg2019-05-31
    Drug · Prescription · Approval201903657
  • MFDS drugCiloretal SR Cap. 200mg2019-05-31
    Drug · Prescription · Approval201903658
  • MFDS drugRaqunin Tab.Revoked2019-05-31
    Drug · Prescription · Approval201903631
  • MFDS drugGuardibone Tab.2019-05-31
    Drug · Prescription · Approval201903619
  • MFDS drugVikaronce Tab. 5/20mg2019-05-29
    Drug · Prescription · Approval201903523
  • MFDS drugVikaronce Tab. 5/40mg2019-05-29
    Drug · Prescription · Approval201903524
  • MFDS drugVikaronce Tab. 10/40mg2019-05-29
    Drug · Prescription · Approval201903525
  • MFDS drugSaporin SR Tab. 300mg2019-05-28
    Drug · Prescription · Approval201903508
  • MFDS drugQ-Phen Inj.2019-05-17
    Drug · Prescription · Approval201903214
  • MFDS drugEyenuri Eye Drops. 0.1%(single use)2019-05-13
    Drug · Prescription · Notification201903078
  • MFDS drugPivaglo Tab. 2mg2019-02-26
    Drug · Prescription · Approval201901224
  • MFDS drugAvogro Tab. 0.5mg2018-07-09
    Drug · Prescription · Approval201802838
  • MFDS drugR-Thioctad Tab. 480mg2017-12-22
    Drug · Prescription · Approval201708551
  • MFDS drugTamisphen 8 hours ER Tab.2017-09-28
    Drug · OTC · Approval201707307
  • MFDS drugGlolion Tab. 10mg2017-07-18
    Drug · Prescription · Approval201705744
  • MFDS drugGuardbone Tab.Revoked2017-07-10
    Drug · Prescription · Approval201705486
  • MFDS drugUmckaba Tab.2017-01-04
    Drug · Prescription · Notification201700100
  • MFDS drugGlofenac Inj.2016-11-30
    Drug · Prescription · Notification201606827
  • MFDS drugRisero Plus Tab.2016-11-29
    Drug · Prescription · Approval201606800
  • MFDS drugHighglin Inj.2016-11-15
    Drug · Prescription · Notification201606627
  • MFDS drugTwynhit Tab. 80/5mg2016-09-30
    Drug · Prescription · Approval201605772

Showing the 80 most recent of 203 records.

Clinical trials

data.go.kr

1 MFDS clinical trial authorisations · 2025 (Bioequivalence 1)

  • Bioequivalence글로피도그렐정(클로피도그렐황산염)2025-10-02

    2 trial sites

R&D and key agreements

Source: DART corporate disclosure

Idetrexed · FRα(엽산수용체 알파) 발현 종양(난소암·자궁내막암·췌장암·유방암 등) · 임상1상 완료, 국내 임상2상 추진 · An anticancer candidate targeting folate receptor alpha (FRα); Phase 1 showed a significant treatment response in FRα-high patients, and the company licensed it in in February 2026 to pursue a domestic Phase 2 trial.

AGK-102 · TM4SF4 표적 항암 · An antibody-based anticancer candidate targeting TM4SF4.

Not yet compiled: business overview. Send us materials and we will add them

Companies in the same categoryPharma & CDMO

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

HANDOK Inc.85

KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.

HL GENOMICS Co., Ltd.85
Kolmar BioTech, Inc.85

Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition